272 related articles for article (PubMed ID: 30210815)
1. Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition.
Kessler AF; Frömbling GE; Gross F; Hahn M; Dzokou W; Ernestus RI; Löhr M; Hagemann C
Cell Death Discov; 2018; 4():12. PubMed ID: 30210815
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields.
Chang E; Pohling C; Beygui N; Patel CB; Rosenberg J; Ha DH; Gambhir SS
J Neurooncol; 2017 Sep; 134(2):259-268. PubMed ID: 28681243
[TBL] [Abstract][Full Text] [Related]
3. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
4. Thymidine decreases the DNA damage and apoptosis caused by tumor-treating fields in cancer cell lines.
Jeong H; Jo Y; Yoon M; Hong S
Genes Genomics; 2021 Sep; 43(9):995-1001. PubMed ID: 33950471
[TBL] [Abstract][Full Text] [Related]
5. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.
Tanzhu G; Chen L; Xiao G; Shi W; Peng H; Chen D; Zhou R
Cell Death Discov; 2022 Oct; 8(1):416. PubMed ID: 36220835
[TBL] [Abstract][Full Text] [Related]
6. Tumor treating fields: a new standard treatment for glioblastoma?
Taillibert S; Le Rhun E; Chamberlain MC
Curr Opin Neurol; 2015 Dec; 28(6):659-64. PubMed ID: 26551239
[TBL] [Abstract][Full Text] [Related]
7. Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging.
Le HT; Staelens M; Lazzari D; Chan G; Tuszyński JA
Cells; 2022 Aug; 11(17):. PubMed ID: 36078119
[TBL] [Abstract][Full Text] [Related]
8. Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.
Krex D; Bartmann P; Lachmann D; Hagstotz A; Jugel W; Schneiderman RS; Gotlib K; Porat Y; Robel K; Temme A; Giladi M; Michen S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902447
[TBL] [Abstract][Full Text] [Related]
9. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z
JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields.
Linder B; Schiesl A; Voss M; Rödel F; Hehlgans S; Güllülü Ö; Seifert V; Kögel D; Senft C; Dubinski D
Front Oncol; 2021; 11():715031. PubMed ID: 34395289
[TBL] [Abstract][Full Text] [Related]
11. Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics.
Voloshin T; Schneiderman RS; Volodin A; Shamir RR; Kaynan N; Zeevi E; Koren L; Klein-Goldberg A; Paz R; Giladi M; Bomzon Z; Weinberg U; Palti Y
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080774
[TBL] [Abstract][Full Text] [Related]
12. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3.
Kim JY; Jo Y; Oh HK; Kim EH
Am J Cancer Res; 2020; 10(10):3475-3486. PubMed ID: 33163284
[TBL] [Abstract][Full Text] [Related]
14. Alternating Electric Fields (TTFields) Activate Ca
Neuhaus E; Zirjacks L; Ganser K; Klumpp L; Schüler U; Zips D; Eckert F; Huber SM
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669316
[TBL] [Abstract][Full Text] [Related]
15. Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells.
Strack M; Kückelhaus J; Diebold M; Wuchter P; Huber PE; Schnell O; Sankowski R; Prinz M; Grosu AL; Heiland DH; Nicolay NH; Rühle A
J Neurooncol; 2024 Jun; ():. PubMed ID: 38900237
[TBL] [Abstract][Full Text] [Related]
16. Tumor treating fields increases membrane permeability in glioblastoma cells.
Chang E; Patel CB; Pohling C; Young C; Song J; Flores TA; Zeng Y; Joubert LM; Arami H; Natarajan A; Sinclair R; Gambhir SS
Cell Death Discov; 2018; 4():113. PubMed ID: 30534421
[TBL] [Abstract][Full Text] [Related]
17. Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma.
Lacouture ME; Anadkat MJ; Ballo MT; Iwamoto F; Jeyapalan SA; La Rocca RV; Schwartz M; Serventi JN; Glas M
Front Oncol; 2020; 10():1045. PubMed ID: 32850308
[No Abstract] [Full Text] [Related]
18. Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields).
Nickl V; Schulz E; Salvador E; Trautmann L; Diener L; Kessler AF; Monoranu CM; Dehghani F; Ernestus RI; Löhr M; Hagemann C
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358594
[TBL] [Abstract][Full Text] [Related]
19. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.
Giladi M; Munster M; Schneiderman RS; Voloshin T; Porat Y; Blat R; Zielinska-Chomej K; Hååg P; Bomzon Z; Kirson ED; Weinberg U; Viktorsson K; Lewensohn R; Palti Y
Radiat Oncol; 2017 Dec; 12(1):206. PubMed ID: 29284495
[TBL] [Abstract][Full Text] [Related]
20. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
Wang Y; Pandey M; Ballo MT
Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]